Global pharma giant Novartis is expanding its US manufacturing capabilities amid concerns over rising pharmaceutical tariffs. The company’s move follows similar investments by Eli Lilly and Johnson & Johnson, which have announced plans to increase production in the country. With US tariffs on pharmaceuticals expected to be implemented soon, Novartis aims to strengthen its supply chain and mitigate potential disruptions to its operations.
Source: https://endpts.com/novartis-follows-lilly-and-jj-in-announcing-multibillion-dollar-us-manufacturing-investment